Clinical Trial Detail

NCT ID NCT01606878
Title Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Oncology Group
Indications

Advanced Solid Tumor

anaplastic large cell lymphoma

Therapies

Dexamethasone + Doxorubicin + Vincristine Sulfate

Cyclophosphamide + Topotecan

Crizotinib

Age Groups: child

No variant requirements are available.